We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
NMRA icon
376
Neumora Therapeutics
NMRA
$76.2M
$76.2M $0.4057 2.48%
ACRV icon
377
Acrivon Therapeutics
ACRV
$75.4M
$75.4M $1.76 3.83%
TELO icon
378
Telomir Pharmaceuticals
TELO
$74.4M
$74.4M $1.01 0.98%
CRDF icon
379
Cardiff Oncology
CRDF
$72.2M
$72.2M $0.9280 1.17%
NTRB icon
380
Nutriband
NTRB
$70.6M
$70.6M $5.81 5.37%
PMVP icon
381
PMV Pharmaceuticals
PMVP
$69.5M
$69.5M $1.30 4.41%
MNOV icon
382
MediciNova
MNOV
$69.4M
$69.4M $1.41 0%
RANI icon
383
Rani Therapeutics
RANI
$67.8M
$67.8M $0.5876 2.88%
CING icon
384
Cingulate
CING
$67.8M
$67.8M $4.66 0%
CGTX icon
385
Cognition Therapeutics
CGTX
$66.6M
$66.6M $0.7006 6.16%
FBIO icon
386
Fortress Biotech
FBIO
$66.4M
$66.4M $1.99 2.58%
CSBR icon
387
Champions Oncology
CSBR
$66.3M
$66.3M $4.76 1.86%
TENX icon
388
Tenax Therapeutics
TENX
$65.9M
$65.9M $1.76 7.98%
SPRO icon
389
Spero Therapeutics
SPRO
$65.8M
$65.8M $1.13 3.42%
VRCA icon
390
Verrica Pharmaceuticals
VRCA
$65.8M
$65.8M $3.83 5.51%
ONCY icon
391
Oncolytics Biotech
ONCY
$65.6M
$65.6M $0.5002 2.19%
APLM icon
392
Apollomics
APLM
$64.1M
$64.1M $22 1.9%
XBIT icon
393
XBiotech
XBIT
$60.1M
$60.1M $1.97 1.01%
CRBU icon
394
Caribou Biosciences
CRBU
$60M
$60M $0.5600 2.87%
GOSS icon
395
Gossamer Bio
GOSS
$57.9M
$57.9M $9.46 3.37%
RNXT icon
396
RenovoRx
RNXT
$57.3M
$57.3M $1.27 3.25%
HYFT icon
397
MindWalk Holdings
HYFT
$56.5M
$56.5M $1.20 5.51%
BOLD icon
398
Boundless Bio
BOLD
$56.4M
$56.4M $2.44 0%
GANX icon
399
Gain Therapeutics
GANX
$56.3M
$56.3M $1.29 8.4%
HRTX icon
400
Heron Therapeutics
HRTX
$56.2M
$56.2M $0.2962 12.6%
14 15
16
17 18

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.26T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $136B, Regeneron Pharmaceuticals (REGN) at $84.3B and Moderna (MRNA) at $80.9B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.